FOXM1 and prostate carcinoma: Recently, it is observed that FOXM1 expression has a potential prognostic value for prostate cancer, however, there is some evidence verifying that miR-877-5p can improve chondrocyte function of experimental osteoarthritis(OA) by targeting FOXM1 as a postulated molecular mechanism [18,39].